Frontlight ResearchEarly access
Trial site
Border Medical Oncology Research Unit
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Prostate cancer2 trials
- Acute myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 310 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Gilead Sciences2 trials
- IO Biotech1 trial
- Ionis Pharmaceuticals, Inc.1 trial
- Mario Negri Institute for Pharmacological Research1 trial
- Nordic Lymphoma Group1 trial
- and 6 more
Running trials
Active, not recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026